Medicare announces coverage criteria for Dexcom G5, but blocks use of smartphones?

Coming sooner than expected, Medicare recently clarified coverage criteria for the Dexcom G5, paving the way for Medicare to reimburse for people with both Type 1 and Type 2 Diabetes requiring intensive insulin dosing to use the Dexcom G5 mobile. Dexcom and the diabetes community heralded the exciting news, as the lack of CGM coverage for Medicare patients had previously

read more

Devices aren’t drugs: Insurance companies should not dictate diabetes technology

The diabetes community has been set ablaze after UnitedHealthcare announced an agreement for Medtronic devices to be the “preferred” in-network, durable medical equipment (DME) provider of insulin pumps. Starting July 1, 2016, UnitedHealthcare patients will be funneled toward using a Medtronic insulin pump instead of offerings from manufacturers like Tandem and Animas.

read more

Accu-Chek Aviva Connect adds Apple Health compatibility

In a highly anticipated move, Roche released a software update to the Accu-chek Aviva Connect iOS app introducing Healthkit support to their wireless glucose meter. As previously discussed, the integration of Healthkit within meters from the two biggest glucose meter manufacturers (Roche Accu-Chek Aviva Connect and the Lifescan Verio Sync) signals a key turning point in the evolution of the smartphone’s role in managing diabetes.

read more